[Trimetazidine-a new aetiology for extrapyramidal disorders: A case of parkinsonism and akathisia].

Suppr

超能文献

作者信息

Masmoudi Kamel, Gras-Champel Valérie, Douadi Youssef, Masson Henri, Andréjak Michel

出版信息

Therapie. 2005 Nov-Dec;60(6):603-5. doi: 10.2515/therapie:2005090.

DOI:10.2515/therapie:2005090

PMID:16555505

Abstract

摘要

相似文献

[Trimetazidine-a new aetiology for extrapyramidal disorders: A case of parkinsonism and akathisia].

Therapie. 2005 Nov-Dec;60(6):603-5. doi: 10.2515/therapie:2005090.

Reversible Parkinsonism linked to trimetazidine (continued).

Prescrire Int. 2006 Aug;15(84):136.

Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases.

Fundam Clin Pharmacol. 2012 Apr;26(2):198-203. doi: 10.1111/j.1472-8206.2011.01008.x. Epub 2011 Nov 2.

Trimetazidine induces parkinsonism, gait disorders and tremor.

Therapie. 2005 Jul-Aug;60(4):419-22. doi: 10.2515/therapie:2005061.

Association between Trimetazidine and Parkinsonism: A Population-Based Study.

Neuroepidemiology. 2019;52(3-4):220-226. doi: 10.1159/000497613. Epub 2019 Mar 4.

Reversible Parkinsonism linked to trimetazidine.

Prescrire Int. 2005 Apr;14(76):63.

Trimetazidine: a new cause for drug-induced parkinsonism?

Mov Disord. 2005 Aug;20(8):1080-1. doi: 10.1002/mds.20574.

[Trimetazidine-induced parkinsonism].

Neurologia. 2004 Sep;19(7):392-5.

[Idaptan(®) (trimetazidine): the panacea].

Aten Primaria. 2013 Apr;45(4):226-7. doi: 10.1016/j.aprim.2012.11.006. Epub 2013 Jan 17.

[Trimetazidine (Preductal). A new approach in controlling myocardial ischemia].

Ter Arkh. 1996;68(8):57-63.

引用本文的文献

Trimetazidine Use in Parkinson's Disease: Is It a Resolved Problem?

eNeuro. 2021 May 19;8(3). doi: 10.1523/ENEURO.0452-20.2021. Print 2021 May-Jun.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Trimetazidine-a new aetiology for extrapyramidal disorders: A case of parkinsonism and akathisia].

Therapie. 2005 Nov-Dec;60(6):603-5. doi: 10.2515/therapie:2005090.

Reversible Parkinsonism linked to trimetazidine (continued).

Prescrire Int. 2006 Aug;15(84):136.

Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases.

Fundam Clin Pharmacol. 2012 Apr;26(2):198-203. doi: 10.1111/j.1472-8206.2011.01008.x. Epub 2011 Nov 2.

Trimetazidine induces parkinsonism, gait disorders and tremor.

Therapie. 2005 Jul-Aug;60(4):419-22. doi: 10.2515/therapie:2005061.

Association between Trimetazidine and Parkinsonism: A Population-Based Study.

Neuroepidemiology. 2019;52(3-4):220-226. doi: 10.1159/000497613. Epub 2019 Mar 4.

Reversible Parkinsonism linked to trimetazidine.

Prescrire Int. 2005 Apr;14(76):63.

Trimetazidine: a new cause for drug-induced parkinsonism?

Mov Disord. 2005 Aug;20(8):1080-1. doi: 10.1002/mds.20574.

[Trimetazidine-induced parkinsonism].

Neurologia. 2004 Sep;19(7):392-5.

[Idaptan(®) (trimetazidine): the panacea].

Aten Primaria. 2013 Apr;45(4):226-7. doi: 10.1016/j.aprim.2012.11.006. Epub 2013 Jan 17.

[Trimetazidine (Preductal). A new approach in controlling myocardial ischemia].

Ter Arkh. 1996;68(8):57-63.

引用本文的文献

Trimetazidine Use in Parkinson's Disease: Is It a Resolved Problem?

eNeuro. 2021 May 19;8(3). doi: 10.1523/ENEURO.0452-20.2021. Print 2021 May-Jun.